Decoralin [AT5]

General Information


DRACP ID  DRACP02216

Peptide Name   Decoralin [AT5]

Sequence  QLLLLIRKLIL

Sequence Length  11

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic (Derived from Decoralin)

Type  Synthetic peptide

Classification

  

Active ACP Membrane lysis Tumor-homing peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma EC50=63±1 μM MTT assay 24/72 h 1
A549 Lung adenocarcinoma Carcinoma EC50>100 μM MTT assay 24/72 h 1
1205Lu Melanoma Carcinoma EC50=44±1 μM MTT assay 24/72 h 1
Jurkat Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia EC50=39±1 μM MTT assay 24/72 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  HDMEC: EC50=271±1 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02216

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C65H122N16O13

Absent amino acids  ACDEFGHMNPSTVWY

Common amino acids  L

Mass  151436

Pl  11.65

Basic residues  2

Acidic residues  0

Hydrophobic residues  8

Net charge  2

Boman Index  1335

Hydrophobicity  180.91

Aliphatic Index  283.64

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26119906

Title  Multidimensional Design of Anticancer Peptides

Doi 10.1002/anie.201504018

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.